Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2013 Sep;11 Suppl 4(Suppl 4):s33-9.
doi: 10.2450/2013.007s.

Clinical use of polyvalent immunoglobulins

Isabella Quinti  1 , Anna Maria Pesce  1 , Livia Bonanni  1 , Carlotta Rubino  1 , Federica Pulvirenti  1 , Cinzia Milito  1
Affiliations
Review

Clinical use of polyvalent immunoglobulins

Isabella Quinti et al. Blood Transfus. 2013 Sep.
No abstract available

PubMed Disclaimer

Figures

Figure 1
Figure 1
(a): Percentages of European patients affected by primary immune deficiencies according to the different clinical entities (only data of patients affected by antibody deficiencies are shown). (b): distribution of European patients according to their paediatric or adult ages. Data from the registry of the European Society for Primary Immune Deficiencies refer to year 2012.
See this image and copyright information in PMC

References

    1. Provan D, Chapel HM, Sewell WA, O’Shaughnessy D. Prescribing intravenous immunoglobulin: summary of Department of Health guidelines. BMJ. 2008;337:a1831. - PubMed
    1. Delforge M, Farber CM, Spath P, et al. Recommended indications for the administration of polyclonal immunoglobulin preparations. Acta Clin Belg. 2011;66:346–60. - PubMed
    1. Liumbruno GM, Bennardello F, Lattanzio A, et al. Recommendations for the use of albumin and immunoglobulins. Blood Transfus. 2009;7:216–34. - PMC - PubMed
    1. O’Shaughnessy D, editor. Third National Immunoglobulin Database Report (2012) Manchester: Medical Data Services and Solutions; 2013. [Accessed on 11/09/2013]. Available at: http://www.ivig.nhs.uk/documents/Third_National_Immunoglobulin_Database_....
    1. Orange JS, Hossny EM, Weiler CR. Use of intravenous immunoglobulin in human disease: a review of evidence by members of the Primary Immunodeficiency Committee of the American Academy of Allergy, Asthma and Immunology. J Allergy Clin Immunol. 2006;117:S525–53. - PubMed

MeSH terms

Substances

LinkOut - more resources